跳至主要内容
临床试验/NCT00846222
NCT00846222Unknown3 期

Adjunctive Mild Hypothermia Therapy to Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated With Shock: A Feasibility Study

Assaf-Harofeh Medical Center1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2009年2月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
入组人数
10
试验地点
1
主要终点
Primary en point: presence of major adverse cardiac events (MACE) MACE definition: death and non-fatal re-infarction.

研究概览

简要总结

The purpose of this study is evaluate the safety and feasibility of mild therapeutic hypothermia (TH) during and 12 hours after primary percutaneous coronary intervention for acute myocardial infarction complicated with shock

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 88 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Recent myocardial infarction: 24 hours of start pain
  • •Pump failure cardiogenic shock (defined as persistent hypotension, systolic BP < 90 mmHg, despite fluids and catecholamines infusion, with tissue hypoperfusion signs
  • •Candidate for immediate percutaneous reperfusion
  • •Maximal care support: mechanical ventilation, intraaortic balloon contrapulsation

排除标准

  • •Cardiogenic shock related to mechanical complication: free wall rupture, acute mitral regurgitation, acute VSD, tamponade
  • •Pregnant women
  • •Absence of maximal support care

研究组 & 干预措施

Mild theraputic hypothermia

Experimental

干预措施: Hypothermia (Procedure)

结局指标

主要结局

Primary en point: presence of major adverse cardiac events (MACE) MACE definition: death and non-fatal re-infarction.

时间窗: 30 days

次要结局

  • Infarct size calculated by area under thr curve creatinine kinase according consecutive samples Reversal stunning by blinded observer echocardiographic assessment(30 days)

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验